Role of Cdc2 in HPV E6-mediated Apoptosis
Role of Cdc2 in HPV E6-mediated Apoptosis
批准号:
7081360
负责人:
JASON J CHEN
金额:
$7.93万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2007-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Infection with the human papillomaviruses (HPV) induces warts and is strongly associated with the development of cervical cancer. Our long-term goal is to elucidate the molecular basis for HPV-induced lesions and to develop therapeutic strategies for the elimination of HPV infection, Apoptosis is a genetically programmed process of cellular destruction that can eliminate virally infected cells or tumors. Viruses such as HPV have evolved specific gene products to modulate apoptosis. Induction of apoptosis is a desirable approach in treating HPV-induced lesions. The HPV E6 gene is essential for viral replication and induces apoptosis. However, the mechanism by which E3 mediates cellular sensitization to apoptosis remains to be determined. To understand the molecular basis for E6-mediated apoptosis, we have established human keratinocytes expressing HPV E6 and found these cells to be susceptible to apoptosis induced by chemotherapeutic agents. To identify genes responsible for E6-mediated apoptosis, a proteomic approach was taken. Significantly, the level and activity of Cdc2, the cyclin-dependent kinase required for cells to enter mitosis and whose aberrant activation has been associated with apoptosis, was increased in E6-expressing cells undergoing apoptosis. An E6 mutant that is unable to activate Cdc2 is defective in sensitizing cells to apoptosis. Moreover, inhibition of Cdc2 activity with specific inhibitor reduced ap6ptosis. We hypothesize that activation of Cdc2 plays an important role in E6-mediated cellular sensitization to apoptosis. The specific aim of this proposal is designed to test this possibility with the following approaches: (1) to examine the relevance of Cdc2 to E6-mediated cellular sensitization to apoptosis through a genetic approach and (2) to determine the role of Cdc2 in E6-mediated apoptosis by molecular ablation and ectopic expression. These studies will help understand the mechanism of E6-mediated apoptosis and contribute to the development of therapeutic approaches against HPV-induced diseases.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Activation of Cdc2 contributes to apoptosis in HPV E6 expressing human keratinocytes in response to therapeutic agents.
Cdc2 的激活有助于表达 HPV E6 的人角质形成细胞响应治疗剂而发生凋亡。
DOI:
10.1016/j.jmb.2007.09.031
发表时间:
2007
期刊:
Journal of molecular biology
影响因子:
5.6
作者:
[Liu,Zhi-Guo, Zhao,Li-Na, Liu,Ying-Wang, Li,Ting-Ting, Fan,Dai-Ming, Chen,JasonJ]
通讯作者:
Chen,JasonJ
Induction of genomic instability by HPV E6 and E7
-
批准号:7900009
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2008
-
负责人:JASON J CHEN
-
依托单位:
Induction of genomic instability by HPV E6 and E7
-
批准号:8103880
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2008
-
负责人:JASON J CHEN
-
依托单位:
Induction of genomic instability by HPV E6 and E7
-
批准号:8305656
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2008
-
负责人:JASON J CHEN
-
依托单位:
Induction of genomic instability by HPV E6 and E7
-
批准号:7467125
-
项目类别:
-
资助金额:$30.55万
-
财政年份:2008
-
负责人:JASON J CHEN
-
依托单位:
Modulation of a novel cell cycle checkpoint by the HPV oncogene E6
-
批准号:7388406
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2008
-
负责人:JASON J CHEN
-
依托单位:
Modulation of a novel cell cycle checkpoint by the HPV oncogene E6
-
批准号:7554131
-
项目类别:
-
资助金额:$20.31万
-
财政年份:2008
-
负责人:JASON J CHEN
-
依托单位:
Induction of genomic instability by HPV E6 and E7
-
批准号:7684264
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2008
-
负责人:JASON J CHEN
-
依托单位:
Role of Cdc2 in HPV E6-mediated Apoptosis
-
批准号:6967225
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2005
-
负责人:JASON J CHEN
-
依托单位:
HPV E6 Inhibitors for AIDS-Associated Malignancies
-
批准号:6888305
-
项目类别:
-
资助金额:$21.87万
-
财政年份:2004
-
负责人:JASON J CHEN
-
依托单位:
HPV E6 Inhibitors for AIDS-Associated Malignancies
-
批准号:6799495
-
项目类别:
-
资助金额:$21.8万
-
财政年份:2004
-
负责人:JASON J CHEN
-
依托单位:
Novel Approach to Cervical Cancer Prevention
-
批准号:6401125
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2001
-
负责人:JASON J CHEN
-
依托单位:
Novel Approach to Cervical Cancer Prevention
-
批准号:6522837
-
项目类别:
-
资助金额:$7.93万
-
财政年份:2001
-
负责人:JASON J CHEN
-
依托单位:
Novel Approach to Cervical Cancer Prevention
-
批准号:6557986
-
项目类别:
-
资助金额:$7.88万
-
财政年份:2001
-
负责人:JASON J CHEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: